9613 NTT DATA Corporation

NTT DATA Appoints Michael Petersen, M.D., as Chief Clinical Innovation Officer

, a global digital business and IT services leader, today announced Michael Petersen, M.D. has joined as the new Chief Clinical Innovation Officer. Dr. Petersen is dedicated to helping clients solve complex challenges around health equity and social care in which data, analytics and technology can be applied to make a meaningful shift towards positive human-centric healthcare experiences.

This press release features multimedia. View the full release here:

Michael Petersen, M.D. has joined NTT DATA as the new Chief Clinical Innovation Officer (Photo: Business Wire)

Michael Petersen, M.D. has joined NTT DATA as the new Chief Clinical Innovation Officer (Photo: Business Wire)

“We are honored to welcome Dr. Petersen to the team,” said Mary Edwards, President, Healthcare Provider, NTT DATA Services. “His clinical background, compassionate leadership style and advocacy for the underserved will help propel innovation forward at a time when we need to reimagine and redefine health and wellbeing to be more human-empowered, knowledge-driven and technology-enabled.”

“Dr. Petersen’s deep industry knowledge of emerging technologies and strategies that improve quality, cost of care and patient outcomes make him an instrumental part of our growing healthcare consulting leadership team,” said Dan Albright, Divisional President, Global Head of Consulting, NTT DATA Services. “Known as an industry thought leader in health equity, he continues to explore new ways to understand and engage with underserved communities through culturally competent experiences. He collaborates with an advanced ecosystem of partners to improve access to care by bringing together individuals and communities with a common goal of better and long-lasting health and wellbeing.”

COVID-19 forever changed the healthcare landscape, shedding new light on the gaps in our healthcare system. NTT DATA is continually searching for ways to expand its commitment to work with clients and organizations such as HLTH to achieve better health and wellbeing. NTT DATA recently became a Title and Lead sponsor for HLTH’s Health Equity Impact Program, which is part of the that is putting a spotlight on important voices, issues, challenges and progress in our reckoning with health equity. As NTT DATA’s Chief Clinical Innovation Officer, Dr. Petersen will help us develop the agenda and lead discussions that will address topics such as product and service design, chronic care, finance models, technology access and the use of tech tools metrics to correct inequities and deliver on services that improve health justice.

NTT DATA Services is a recognized leader in IT and business services including cloud, data and applications. A division of NTT DATA headquartered in Texas, the company leverages consulting and deep industry expertise to help clients accelerate and sustain value throughout their digital journeys. Visit or to learn more.

About NTT DATA

NTT DATA – a part of NTT Group – is a trusted global innovator of IT and business services headquartered in Tokyo. We help clients transform through consulting, industry solutions, business process services, digital & IT modernization and managed services. NTT DATA enables them, as well as society, to move confidently into the digital future. We are committed to our clients’ long-term success and combine global reach with local client attention to serve them in over 50 countries around the globe. Visit us at

EN
28/04/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on NTT DATA Corporation

Chris Hoare
  • Chris Hoare

NTT Corp (Buy, TP: ¥215, +39%) Q3 FY25 Quick Take: ARPU recovery cont...

NTT's 3Q results largely improved. Key points to note is the continued recovery in ARPU in mobile, and continued revenue recovery in the Global Solutions and Regional business. However, mobile marketing spend has dented profitability again, with management revising guidance for full year 2025 across the board downwards. We continue to be Buyers but prefer KDDI and SB (our top pick among the 3 Japanese incumbents).

Chris Hoare
  • Chris Hoare

NTT Corp (Buy, TP: ¥215, +39%) Q2 FY25 Quick Take: Better as Mobile AR...

NTT printed a better set of Q2 results. Key points to note are ARPU inflection in mobile, recovery in Global Solutions, and continued revenue recovery in the Regional business.

Lindsay Whipp
  • Lindsay Whipp

PSA IT Services: Japanese Banking Industry’s Investment in DX Deepens

The most recent quarterly earnings for the system integrators highlighted the sustained increase in spending by Japanese financial institutions over recent quarters, as they seek to improve products and services amid a shift in interest rates and the introduction of tax-exempt investment accounts, and as interest in digital currencies grows. Analyst Lindsay Whipp reviews some of the DX spending undertaken by Japan’s banking industry and highlights beneficiaries'.

Chris Hoare
  • Chris Hoare

Japanese Telcos – Q1 FY25 review: Steady start, all eyes on Mobile pri...

Revenue trends were steady as the softer mobile growth was offset by improvement in non-mobile. Softbank remained the outperformer, but this has already been baked in as expectations for Group revenue are sitting ahead of guidance by 3%.

Chris Hoare
  • Chris Hoare

NTT (Buy, TP: ¥215, +40%) Q1 FY25 Quick Take: Soft start; awaiting fo...

NTT printed a rather soft set of Q1 results as Mobile was weaker and Global Solutions was impacted by FX weakness in its Overseas arm. The recovery in Regional Communications offered some encouragement and is likely to remain so as the firm transits from Copper to Fibre over the long run.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch